Subsensitive alpha-2-adrenoceptor function in male alcohol-dependent individuals during 6 months of abstinence

Drug and Alcohol Dependence

Volumn 57, Issue 3, 2000, Pages 255-260

  Berggren, Ulf ^a   Fahlke, Claudia ^b   Norrby, Axel ^a   Zachrisson, Olof ^a   Balldin, Jan ^a  

^a Institute of Clinical Neuroscience   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Alcohol withdrawal; Clonidine; Growth hormone; Noradrenergic activity

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA 2 ADRENERGIC RECEPTOR; ASPARTATE AMINOTRANSFERASE; CITALOPRAM; CLOMETHIAZOLE; CLONIDINE; DISULFIRAM;

ADRENERGIC ACTIVITY; ADULT; ALCOHOL ABSTINENCE; ALCOHOL WITHDRAWAL; ALCOHOLISM; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; GROWTH HORMONE RELEASE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LIVER FUNCTION; MALE; MENTAL DISEASE; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; RECEPTOR SENSITIVITY;

ADULT; AGED; ALCOHOLISM; CLONIDINE; DOWN-REGULATION; ETHANOL; HUMAN GROWTH HORMONE; HUMANS; MALE; MIDDLE AGED; RECEPTORS, ADRENERGIC, ALPHA-2; RECEPTORS, PRESYNAPTIC; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 0033990303     PISSN: 03768716     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0376-8716(99)00051-4     Document Type: Article

References (27)

1. Balldin J., Granérus A.-K., Lindstedt G., Modigh K., Wålinder J. Neuroendocrine evidence for increased responsiveness of dopamine receptors in humans following electroconvulsive therapy. Psychopharmacology. 76:1982;371-376.
2. Balldin J., Berggren U., Engel J., Lindstedt G., Sundkler A., Wålinder J. Alpha-2-adrenoceptor sensitivity in early alcohol withdrawal. Biol. Psychiatry. 31:1992;712-719.
3. Balldin J., Berggren U., Eriksson E., Lindstedt G., Sundkler A. Guanfacine as an alpha-2-agonist inducer of growth hormone secretion - a comparison with clonidine. Psychoneuroendocrinology. 18:1993;45-55.
4. Bokström K., Balldin J. A rating scale for assessment of alcohol withdrawal psychopathology (AWIP). Alcohol. Clin. Exp. Res. 16:1992;241-249.
5. Borg S., Czarnecka A., Kvande H., Mossberg D., Sedvall G. Clinical conditions and concentrations of MOPEG in the cerebrospinal fluid and urine of male alcoholic patients during withdrawal. Alcohol. Clin. Exp. Res. 7:1983;411-415.
6. De Marinis L., Mancini A., Fiumara C., Conte G., Iacona T., Ianiri L., Zeppetelli E., Gobbi G., Tempesta E. Growth hormone response to growth hormone-releasing hormone in early abstinent alcoholic patients. Psychoneuroendocrinology. 18:1993;475-483.
7. Fahlke, C., Berggren, U., Balldin, J., 1999a. Mental well-being in alcohol withdrawal: relationship to alpha-2-adrenoreceptor function. Alcohol Alcohol. 34.
8. Fahlke, C., Berggren, U., Lundborg, C., Balldin, J. 1999b. Psychopathology in alcohol withdrawal: relationship to alpha-2-adrenoceptor function. Alcohol Alcohol. 34.
9. Gil-Ad I., Gurewitz R., Marcovici O., Rosenfeld J., Laron Z. Effect of aging on human plasma growth hormone response to clonidine. Mech. Ageing Dev. 27:1984;97-100.
10. Glue P., Sellman J.D., Nicholls M.G., Abbott R., Joyce P.R., Nutt D.J. Studies of alpha-2-adrenoceptor function in abstinent alcoholics. Br. J. Addiction. 84:1989;97-102.
11. Hoehe M., Valido G., Matussek N. Growth hormone, noradrenaline, blood pressure and cortisol responses to clonidine in healthy male volunteers: dose-response relations and reproducibility. Psychoneuroendocrinology. 13:1988;409-418.
12. Hunt G.E., O'Sullivan B.T., Johnson G.F.S., Smythe G.A. Growth hormone and cortisol secretion after oral clonidine in healthy adults. Psychoneuroendocrinology. 11:1986;317-325.
13. Majumdar S.K., Shaw G.K., Bridges P.K. The dexamethasone suppression test in chronic alcoholics with and without depression and its relationship to their hepatic status. Drug Alcohol Depend. 21:1988;231-235.
14. Matussek N., Ackenheil M., Herz M. The dependence of the clonidine growth hormone test on alcohol drinking habits and the menstrual cycle. Psychoneuroendocrinology. 9:1984;173-177.
15. Montgomery S.A., Åsberg M. A new depression scale designed to be sensitive to change. Br. J. Psychiatry. 134:1979;382-389.
16. Müller N., Hoehe M., Klein H.E., Nieberle G., Kapfhammer H.P., May F., Müller O.A., Fichter M. Endocrinological studies in alcoholics during withdrawal and after abstinence. Psychoneuroendocrinology. 14:1989;113-123.
17. Nutt D. Altered central alpha-2-adrenoceptor sensitivity in panic disorder. Arch. Gen. Psychiatry. 46:1989;165-169.
18. Nutt D., Glue P., Molyneux S., Clark E. Alpha-2-adrenoceptor function in alcohol withdrawal: a pilot study of the effects of i.v. clonidine in alcoholics and normals. Alcohol. Clin. Exp. Res. 12:1988;14-18.
19. Ogata M., Mendelson J.H., Mello N.K., Majchrowicz E. Adrenal function and alcoholism. Psychosom. Med. 33:1971;159.
20. Schittecatte M., Charles G., Depauw Y., Mesters P., Wilmotte J. Growth hormone response to clonidine in panic disorder patients. Psychiatry Res. 23:1988;147-151.
21. Schuckit M.A. Drug and Alcohol Abuse. A Clinical Guide to Diagnosis and Treatment. 1989;77-95 Plenum, New York.
22. Snaith R.P., Harrop F.M., Newby D.A., Teale C. Grade scores of the Montgomery-Åsberg depression and the clinical anxiety scales. Br. J. Psychiatry. 148:1986;599-601.
23. Tancer M.E., Stein M.B., Uhde T.W. Growth hormone (GH) response to clonidine and growth hormone releasing factor (GRF) in normal controls. Psychoneuroendocrinology. 15:1990;253-259.
24. Tulen J.H.M., van de Wetering B.J.M., Kruijk M.P.C.W., von Saher R.A., Moleman P., Boomsma F., van Steenis H.G., Man in 't Veld A.J. Cardiovascular, neuroendocrine, and sedative responses to four grades doses of clonidine in a placebo-controlled study. Biol. Psychiatry. 32:1992;485-500.
25. Vahl N., Jorgensen J.O., Jurik A.G., Christiansen J.S. Abdominal adiposity and physical fitness are major determinants of the age associated decline in stimulated GH secretion in healthy adults. J. Clin. Endocrinol. Metab. 81:1996;2209-2215.
26. Valverius P., Högström-Brandt A.-M., Borg S. Norepinephrine metabolite in CSF correlates with ethanol consumption and heredity in humans. Alcohol. Clin. Exp. Res. 10:1993;499-503.
27. Wiesbeck G.A., Mueller T., Wodarz N., Davids E., Kraus T., Thome J., Weijers H.G., Boening J. Growth hormone response to placebo, apomorphine and growth hormone releasing hormone in abstinent alcoholics and control subjects. Drug Alcohol Depend. 52:1998;53-56.